Colon Cancer News

CancerConnect colon cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of colon cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of colon cancer treatment and survivorship.

Share

Colon Cancer News


TAS-102 Improves Survival in Advanced Colorectal Cancer (July 9, 2014)

Researchers recently reported that the new combination agent TAS-102 improves overall survival in patients whose metastatic colorectal cancer is refractory to standard therapies. These results were recently... Continue Reading

More Effective Colorectal Cancer Prevention with Colonoscopy Doctor with High Rate of Polyp Detection (July 3, 2014)

Recent findings suggest that for more effective colorectal cancer prevention, it’s best to choose a physician for colonoscopy with a higher rate of precancerous polyp detection; meaning that he or she... Continue Reading

Study Shows Polypectomy as Effective as Partial Colon Resection (July 2, 2014)

A team from Stony Brook University reported that patients requiring removal of colon polyps could be effectively treated with laparoscopic-assisted polypectomy (LACP) and that the procedure required fewer... Continue Reading

Chemotherapy Regimens Paired with Avastin or Erbitux Extended Survival for Patients with Metastatic Colorectal Cancer (June 20, 2014)

In a plenary session of the American Society of Clinical Oncology (ASCO) meeting in Chicago, researchers reported that treatment of metastatic colorectal cancer with Avastin® (bevacizumab) or Erbitux®... Continue Reading

Web Chat on “Using Radiation to Treat Colorectal Cancers Metastasized to the Liver,” with Sarah Cannon Expert Andrew Kennedy, MD (April 2, 2014)

  Sarah Cannon Radiation Oncology Physician-in-Chief Andrew Kennedy, MD, discusses metastatic colorectal cancer and answers participants’ questions during a live Web chat recorded on April 2, 2014.... Continue Reading

Predicting SIR-Spheres® microspheres Treatment Outcomes for Metastatic Colorectal Cancer (March 5, 2014)

Pre-treatment laboratory tests may play a key role in predicting patient outcomes prior to selective internal radiation therapy for metastatic colorectal cancer, while a new modeling technology for enhancing... Continue Reading

March Is National Colorectal Cancer Awareness Month (March 2, 2014)

Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of colorectal cancer programs for national colorectal cancer awareness month. As the month of March brings colorectal... Continue Reading

Stool Test Spots Most Colon Cancers (February 19, 2014)

A stool test known as the fecal immunochemical test (FIT) is accurate in diagnosing most colorectal cancers, according to a meta-analysis published in the Annals of Internal Medicine. Screening is crucial... Continue Reading

Genomic Health Announces Results of Oncotype DX(R) Colon Cancer Studies Presented at 2014 American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) Symposium (February 7, 2014)

New data show real-life impact of Oncotype DX on treatment decisions, underscore clinical validity and utility of the test REDWOOD CITY, Calif., Jan. 29, 2014 /PRNewswire/ — Genomic Health, Inc.... Continue Reading

Oncotype Validated in Stage II and III Colon Cancer (January 3, 2014)

The Oncotype DX® Recurrence Score® (RS) results predict recurrence risk in stage II and III colon cancer and may better inform adjuvant therapy decisions in this population, according to the results... Continue Reading

More Colon Cancer News

Latest Colon Cancer News By Stage


Screening/Prevention

More Effective Colorectal Cancer Prevention with Colonoscopy Doctor with High Rate of Polyp Detection (July 3, 2014)

Recent findings suggest that for more effective colorectal cancer prevention, it’s best to choose a physician for colonoscopy with a higher rate of precancerous polyp detection; meaning that he or she detects more polyps than colleagues in proportion... Continue Reading

Study Shows Polypectomy as Effective as Partial Colon Resection (July 2, 2014)

A team from Stony Brook University reported that patients requiring removal of colon polyps could be effectively treated with laparoscopic-assisted polypectomy (LACP) and that the procedure required fewer resources than did partial colon resection (laparoscopic... Continue Reading

March Is National Colorectal Cancer Awareness Month (March 2, 2014)

Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of colorectal cancer programs for national colorectal cancer awareness month. As the month of March brings colorectal cancer into focus, it’s time to increase public... Continue Reading

Stool Test Spots Most Colon Cancers (February 19, 2014)

A stool test known as the fecal immunochemical test (FIT) is accurate in diagnosing most colorectal cancers, according to a meta-analysis published in the Annals of Internal Medicine. Screening is crucial for the prevention and early detection of colorectal... Continue Reading

Genomic Health Announces Results of Oncotype DX(R) Colon Cancer Studies Presented at 2014 American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) Symposium (February 7, 2014)

New data show real-life impact of Oncotype DX on treatment decisions, underscore clinical validity and utility of the test REDWOOD CITY, Calif., Jan. 29, 2014 /PRNewswire/ — Genomic Health, Inc. (Nasdaq: GHDX) today announced results from the Oncotype... Continue Reading

More Screening and Prevention

Adjuvant (I-III, A-C) Colon Cancer

Study Shows Polypectomy as Effective as Partial Colon Resection (July 2, 2014)

A team from Stony Brook University reported that patients requiring removal of colon polyps could be effectively treated with laparoscopic-assisted polypectomy (LACP) and that the procedure required fewer resources than did partial colon resection (laparoscopic... Continue Reading

March Is National Colorectal Cancer Awareness Month (March 2, 2014)

Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of colorectal cancer programs for national colorectal cancer awareness month. As the month of March brings colorectal cancer into focus, it’s time to increase public... Continue Reading

Genomic Health Announces Results of Oncotype DX(R) Colon Cancer Studies Presented at 2014 American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) Symposium (February 7, 2014)

New data show real-life impact of Oncotype DX on treatment decisions, underscore clinical validity and utility of the test REDWOOD CITY, Calif., Jan. 29, 2014 /PRNewswire/ — Genomic Health, Inc. (Nasdaq: GHDX) today announced results from the Oncotype... Continue Reading

Oncotype Validated in Stage II and III Colon Cancer (January 3, 2014)

The Oncotype DX® Recurrence Score® (RS) results predict recurrence risk in stage II and III colon cancer and may better inform adjuvant therapy decisions in this population, according to the results of a validation study published in the Journal of... Continue Reading

Oncotype DX Changes Treatment Recommendations in Stage II Colon Cancer (December 26, 2013)

Use of the Oncotype DX® colon cancer test changed treatment recommendations in 29 percent of stage II colon cancer patients, according to the results of a study published in Current Medical Research and Opinion. Stage II colon cancer refers to cancer... Continue Reading

More Adjuvant (I-III, A-C) Colon Cancer

Stage IV (D)/Relapsed Colon Cancer

TAS-102 Improves Survival in Advanced Colorectal Cancer (July 9, 2014)

Researchers recently reported that the new combination agent TAS-102 improves overall survival in patients whose metastatic colorectal cancer is refractory to standard therapies. These results were recently reported at the ESMO 16th World Congress on... Continue Reading

Chemotherapy Regimens Paired with Avastin or Erbitux Extended Survival for Patients with Metastatic Colorectal Cancer (June 20, 2014)

In a plenary session of the American Society of Clinical Oncology (ASCO) meeting in Chicago, researchers reported that treatment of metastatic colorectal cancer with Avastin® (bevacizumab) or Erbitux® (cetuximab) and standard chemotherapy (FOLFOX or... Continue Reading

Web Chat on “Using Radiation to Treat Colorectal Cancers Metastasized to the Liver,” with Sarah Cannon Expert Andrew Kennedy, MD (April 2, 2014)

  Sarah Cannon Radiation Oncology Physician-in-Chief Andrew Kennedy, MD, discusses metastatic colorectal cancer and answers participants’ questions during a live Web chat recorded on April 2, 2014. Topics  include: Difficulties of treating mCRC Treatment... Continue Reading

Predicting SIR-Spheres® microspheres Treatment Outcomes for Metastatic Colorectal Cancer (March 5, 2014)

Pre-treatment laboratory tests may play a key role in predicting patient outcomes prior to selective internal radiation therapy for metastatic colorectal cancer, while a new modeling technology for enhancing delivery of treatment could improve treatment... Continue Reading

March Is National Colorectal Cancer Awareness Month (March 2, 2014)

Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of colorectal cancer programs for national colorectal cancer awareness month. As the month of March brings colorectal cancer into focus, it’s time to increase public... Continue Reading

More Stage IV (D)/Relapsed Colon Cancer

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS